Ovarian hormone modulation of radiation-induced cataractogenesis: Dose-response studies

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 7, 2009, Pages 3304-3310

  Bigsby, Robert M ^a   Valluri, Shailaja ^a   Lopez, Jennifer ^a   Mendonca, Marc S ^a   Caperell Grant, Andrea ^a   des Rosiers, Colleen ^a   Dynlacht, Joseph R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATARACTOGENESIS; CONTROLLED STUDY; DISEASE COURSE; ESTROGEN ACTIVITY; FEMALE; GAMMA IRRADIATION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RADIATION CATARACT; RADIATION DOSE; RAT; ANIMAL; CATARACT; GAMMA RADIATION; LENS; METABOLISM; OVARY; PATHOLOGY; PHYSIOLOGY; RADIATION EXPOSURE; RADIATION INJURY; RADIATION RESPONSE; SPRAGUE DAWLEY RAT;

ANIMALS; CATARACT; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, RADIATION; ESTRADIOL; ESTROGENS; FEMALE; GAMMA RAYS; LENS, CRYSTALLINE; OVARIECTOMY; OVARY; RADIATION INJURIES, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 67649967927     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-3262     Document Type: Article

References (44)

1. Gordon KB, Char DH, Sagerman RH. Late effects of radiation on the eye and ocular adnexa. Int J Radiat Oncol Biol Phys. 1995; 31:1123-1139.
2. Zierhut D, Lohr F, Schraube P, et al. Cataract incidence after total-body irradiation. Int J Radiat Oncol Biol Phys. 2000;46:131-135.
3. van Kempen-Harteveld ML, Belkacemi Y, Kal HB, Labopin M, Frassoni F. Dose-effect relationship for cataract induction after single-dose total body irradiation and bone marrow transplantation for acute leukemia. Int J Radiat Oncol Biol Phys. 2002;52:1367-1374.
4. Frisk P, Hagberg H, Mandahl A, Soderberg P, Lonnerholm G. Cataracts after autologous bone marrow transplantation in children. Acta Paediatr. 2000;89:814-819.
5. van Kempen-Harteveld ML, Struikmans H, Kal HB, et al. Cataract after total body irradiation and bone marrow transplantation: degree of visual impairment. Int J Radiat Oncol Biol Phys. 2002;52: 1375-1380.
6. Merriam GR Jr, Focht EF. A clinical study of radiation cataracts and the relationship to dose. Am J Roentgenol Radium Ther Nucl Med. 1957;77:759-785.
7. Neriishi K, Nakashima E, Minamoto A, et al. Postoperative cataract cases among atomic bomb survivors: radiation dose response and threshold. Radiat Res. 2007;168:404-408.
8. Cucinotta FA, Manuel FK, Jones J, et al. Space radiation and cataracts in astronauts. Radiat Res. 2001;156:460-466.
9. Rastegar N, Eckart P, Mertz M. Radiation-induced cataract in astronauts and cosmonauts. Graefes Arch Clin Exp Ophthalmol. 2002; 240:543-547.
10. Worgul BV. Cataract analysis and the assessment of radiation risk in space. Adv Space Res. 1986;6:285-293.
11. Medvedovsky C, Worgul BV. Neutron effects on the lens. Radiat Res. 1991;128:S103-S110.
12. Klein B, Klein R, Ritter L. Is there evidence of an estrogen effect on age-related lens opacities? The Beaver Dam Eye Study. Arch Ophthalmol. 1994;112:85-91.
13. Benitez del Castillo J, del Rio T, Garcia-Sanchez J. Effects of estrogen use on lens transmittance in postmenopausal women. Ophthalmology. 1997;104:970-973.
14. Cumming R, Mitchell P. Hormone replacement therapy, reproductive factors, and cataract: the Blue Mountains Eye Study. Am J Epidemiol. 1997;145:242-249.
15. Freeman EE, Munoz B, Schein OD, West SK. Hormone replacement therapy and lens opacities: the Salisbury Eye Evaluation project. Arch Ophthalmol. 2001;119:1687-1692.
16. Freeman EE, Munoz B, Schein OD, West SK. Incidence and progression of lens opacities: effect of hormone replacement therapy and reproductive factors. Epidemiology. 2004;15:451-457.
17. Worzala K, Hiller R, Sperduto R, et al. Postmenopausal estrogen use, type of menopause, and lens opacities: the Framingham studies. Arch Intern Med. 2001;161:1448-1454.
18. Dynlacht JR, Tyree C, Valluri S, et al. Effect of estrogen on radiation-induced cataractogenesis. Radiat Res. 2006;165:9-15.
19. Dynlacht JR, Valluri S, Lopez J, et al. Estrogen protects against radiation-induced cataractogenesis. Radiat Res. 2008;170:758-64.
20. DesRosiers C, Mendonca M, Tyree C, et al. Use of the Leksell gamma knife for localized small field lens irradiation in rodents. Technol Cancer Res Treat. 2003;2:449-454.
21. Rubin BL, Dorfman AS, Black L, Dorfman RI. Bioassay of estrogens using the mouse uterine response. Endocrinology. 1951;49:429-439.
22. Dorfman RI, Dorfman AS. Estrogen assays using the rat uterus. Endocrinology. 1954;55:65-69.
23. Diczfalusy E, Magnusson AM, Nilsson L, Westman A. A method of bioassay based on the duration of action of estrogens. Endocrinology. 1957;60:581-588.
24. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci U S A. 1993;90:11162-11166.
25. Hewitt S, Korach K. Oestrogen receptor knockout mice: roles for oestrogen receptors alpha and beta in reproductive tissues. Reproduction. 2003;125:143-149.
26. Sartor CI. Biological modifiers as potential radiosensitizers: targeting the epidermal growth factor receptor family. Semin Oncol. 2000;27:15-20, discussion 92-100.
27. Kovacs CJ, Gooya JM, Harrell JP, McGowan KM, Evans MJ. Altered radioprotective properties of interleukin I alpha (IL-1) in nonhematologic tumor-bearing animals. Int J Radiat Oncol Biol Phys. 1991;20:307-310.
28. Zou H, Adachi M, Imai K, et al. 2-Methoxyestradiol, an endogenous mammalian metabolite, radiosensitizes colon carcinoma cells through c-Jun NH2-terminal kinase activation. Clin Cancer Res. 2006;12:6532-6539.
29. Jordan BF, Christian N, Crokart N, Gregoire V, Feron O, Gallez B. Thyroid status is a key modulator of tumor oxygenation: implication for radiation therapy. Radiat Res. 2007;168:428-432.
30. Shibuya K, Komaki R, Shintani T, et al. Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007;69:1534-1543.
31. Hermann RM, Fest J, Christiansen H, et al. Radiosensitization dependent on p53 function in bronchial carcinoma cells by the isoflavone genistein and estradiol in vitro. Strahlenther Onkol. 2007;183:195-202.
32. Crokart N, Jordan BF, Baudelet C, et al. Glucocorticoids modulate tumor radiation response through a decrease in tumor oxygen consumption. Clin Cancer Res. 2007;13:630-635.
33. Yacoub A, Hawkins W, Hanna D, et al. Human chorionic gonadotropin modulates prostate cancer cell survival after irradiation or HMG CoA reductase inhibitor treatment. Mol Pharmacol. 2007; 71:259-275.
34. Koturbash I, Kutanzi K, Hendrickson K, Rodriguez-Juarez R, Kogosov D, Kovalchuk O. Radiation-induced bystander effects in vivo are sex specific. Mutat Res. 2008;642:28-36.
35. Bolton J. Quinoids, quinoid radicals, and phenoxyl radicals formed from estrogens and antiestrogens. Toxicology. 2002;177:55-65.
36. Cavalieri EL, Li KM, Balu N, et al. Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases. Carcinogenesis. 2002;23: 1071-1077.
37. Sasaki H, Lin LR, Yokoyama T, Sevilla MD, Reddy VN, Giblin FJ. TEMPOL protects against lens DNA strand breaks and cataract in the x-rayed rabbit. Invest Ophthalmol Vis Sci. 1998;39:544-552.
38. Wolf N, Pendergrass W, Singh N, Swisshelm K, Schwartz J. Radiation cataracts: mechanisms involved in their long delayed occurrence but then rapid progression. Mol Vis. 2008;14:274-285.
39. Odrich MG, Hall SJ, Worgul BV, Trokel SL, Rini FJ. Posterior capsule opacification: experimental analyses. Ophthalmic Res. 1985;17:75-84.
40. Worgul BV, Merriam GR, Szechter A, Srinivasan D. Lens epithelium and radiation cataract, I: preliminary studies. Arch Ophthalmol. 1976;94:996-999.
41. Sutherland R, Prall O, Watts C, Musgrove E. Estrogen and progestin regulation of cell cycle progression. J Mammary Gland Biol Neoplasia. 1998;3:63-72.
42. Henderson BE, Feigelson HS. Hormonal carcinogenesis. Carcinogenesis. 2000;21:427-433.
43. Gompel A, Somai S, Chaouat M, et al. Hormonal regulation of apoptosis in breast cells and tissues. Steroids. 2000;65:593-598.
44. Kanda N, Watanabe S. 17β-Estradiol inhibits oxidative stress-induced apoptosis in keratinocytes by promoting Bcl-2 expression. J Invest Dermatol. 2003;121:1500-1509.